These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1714429)

  • 21. Major histocompatibility class II expression in the normal canine cornea and in canine chronic superficial keratitis.
    Williams DL
    Vet Ophthalmol; 2005; 8(6):395-400. PubMed ID: 16359362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between the L-DOPA histofluorescence procedure and the indirect immunofluorescence with anti-T6 and -HLA-DR monoclonal antibodies in visualizing Langerhans cells of human epidermis.
    Crivellato E; Damiani D; Mallardi F
    Acta Histochem; 1990; 88(1):59-64. PubMed ID: 2113342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The distribution of HLA antigens on human corneal tissue.
    Whitsett CF; Stulting RD
    Invest Ophthalmol Vis Sci; 1984 May; 25(5):519-24. PubMed ID: 6370904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of CD1a, HLA-DR, and HLA class I expression on viable human Langerhans cells and keratinocytes.
    Meunier L; Vian L; Lagoueyte C; Lavabre-Bertrand T; Duperray C; Meynadier J; Cano JP
    Cytometry; 1996 Dec; 26(4):260-4. PubMed ID: 8979024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and function of B7 on human epidermal Langerhans cells.
    Symington FW; Brady W; Linsley PS
    J Immunol; 1993 Feb; 150(4):1286-95. PubMed ID: 7679425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Langerhans cells in periimplantar gingival tissues: an immunohistochemical study of 14 cases.
    Maiorano E; Favia G
    Boll Soc Ital Biol Sper; 1994; 70(10-11):257-63. PubMed ID: 7702829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunologic experimental studies on the alkali burn of cornea in rats].
    Zhao M; Chen J; Yang P
    Zhonghua Yan Ke Za Zhi; 2000 Jan; 36(1):40-2, 4. PubMed ID: 11853581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells.
    Meunier L; Gonzalez-Ramos A; Cooper KD
    J Immunol; 1993 Oct; 151(8):4067-80. PubMed ID: 8409386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of Langerhans cells in the central corneas of normal human infants.
    Chandler JW; Cummings M; Gillette TE
    Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):113-6. PubMed ID: 3967954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
    Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD
    J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of human epidermal Langerhans cells in skin immunity.
    Braathen LR
    Derm Beruf Umwelt; 1987; 35(2):58-61. PubMed ID: 2439270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity.
    Ashworth J; Kahan MC; Breathnach SM
    J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD-1 (T6), HLA-DR-expressing cells, presumably Langerhans cells, in nasal mucosa.
    Fokkens WJ; Vroom TM; Rijntjes E; Mulder PG
    Allergy; 1989 Apr; 44(3):167-72. PubMed ID: 2469344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Langerhans cells expressing HLA-DQ, HLA-DR and T6 antigens in normal oral mucosa and lichen planus.
    Chou MJ; Daniels TE
    J Oral Pathol Med; 1989 Dec; 18(10):573-6. PubMed ID: 2621652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-cell repertoire of normal, rejected, and pathological corneas: phenotype and function.
    Wackenheim-Urlacher A; Kantelip B; Falkenrodt A; Piqot X; Tongio MM; Montard M; Delbosc B
    Cornea; 1995 Sep; 14(5):450-6. PubMed ID: 8536456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An immunohistochemical study of Langerhans cells, T-cells and the HLA antigen in human cornea.
    Li Q; He Y
    Yan Ke Xue Bao; 1993 Sep; 9(3):121-5. PubMed ID: 8168605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of antigen presenting cells in the human cornea: correlation of in vivo confocal microscopy and immunohistochemistry in different pathologic entities.
    Mayer WJ; Mackert MJ; Kranebitter N; Messmer EM; Grüterich M; Kampik A; Kook D
    Curr Eye Res; 2012 Nov; 37(11):1012-8. PubMed ID: 22667765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of blood group antigens A and/or B in diseased corneas.
    Ardjomand N; Reich ME; Radner H
    Curr Eye Res; 1998 Jun; 17(6):650-5. PubMed ID: 9663855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cutaneous immune system].
    Schmitt D
    C R Seances Soc Biol Fil; 1994; 188(3):207-21. PubMed ID: 7834504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunology of corneal allograft rejection: HLA-DR antigens on human corneal cells.
    Young E; Stark WJ; Prendergast RA
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):571-4. PubMed ID: 3884541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.